- gsearch

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

- gsearch

Search Results

Narrow Results:

2016 1

Journal Article 1

1 Results

Refine Results

All Collections

Refine Results:

All Collections

Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification

CITE Title : Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification Personal Author(s) : Deans, Richard M.;Morgens, David W.;Ökesli, Ayşe;Pillay, Sirika;Horlbeck, Max A.;Kampmann, Martin;Gilbert, Luke A.;Li, Amy;Mateo, Roberto;Smith, Mark;Glenn, Jeffrey S.;Carette, Jan E.;Khosla, Chaitan;Bassik, Michael C.; Published Date : March 28 2016 Source : Nat Chem Biol. 12(5):361-366 URL : https://stacks.cdc.gov/view/cdc/40994 Deans, Richard M. et al. (2016). Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification. 12(5). Deans, Richard M. et al. "Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification" 12, no. 5 (2016) Deans, Richard M. et al. "Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification" vol. 12, no. 5, 2016 Export RIS Citation Information.

:

Deans, Richard M. ;

Morgens, David W.

March 28 2016 | Nat Chem Biol. 12(5):361-366

:

Broad-spectrum antiviral drugs targeting host processes could potentially treat a wide range of viruses while reducing the likelihood of emergent resi...

To see more results, try removing search filters or changing the search terms